在体细胞重编程中解读驱动命运分叉的决定性因素
Chunshen Long1, Hanshuang Li1, Pengfei Liang1
1State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, Institutes of Biomedical Sciences, School of Life Sciences, Inner Mongolia University, Hohhot 010070, China.
Molecular therapy. Nucleic acids
|October 23, 2023
概括
体细胞重编程涉及持续的细胞命运转换. 这项研究确定了驱动诱导多能干细胞 (iPSCs) 转向树皮样细胞 (SLCs) 或热囊细胞样细胞 (TLCs) 的关键因素,以提高重编程效率.
科学领域:
- 干细胞生物学 干细胞生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 发展生物学 发展生物学
背景情况:
- 体细胞重编程是一个动态的过程,中间体面临着分子瓶.
- 了解细胞命运决策对于有效的重编程到多能性至关重要.
- 之前的研究强调了介质细胞-上皮细胞过渡和多能性网络的激活.
研究的目的:
- 在诱导多能干细胞 (iPSC) 重编程过程中确定控制细胞命运分支的决定性因素.
- 阐明导致状细胞 (SLCs) 与热囊细胞 (TLCs) 差异化的分子驱动因素.
- 通过操纵细胞命运轨迹来提高重编程效率,提供洞察力.
主要方法:
- 细胞轨迹的重建以识别iPSC/SLC和iPSC/TLC的命运分叉.
- 对基因调节网络的分析,以确定关键的转录因子.
- 对与不同细胞命运相关的基因表达模式的比较分析.
主要成果:
- 成功的重编程涉及介质细胞-上皮细胞过渡和多能性网络激活.
- iPSC/SLC命运与细胞周期抑制和细胞外基因基因激活有关.
- iPSC / TLC命运的特点是胎盘发育基因的上调.
- 七个因素 (例如,Taf7,Ezh2,Klf2) 驱动iPSC/SLC重编程,而三个因素 (例如,Cdc5l,Klf4,Nanog) 驱动iPSC/TLC分叉.
- 十一个因素 (例如,Cebpb,Sox4,Junb) 促进SLC命运,四个因素 (例如,Gata2,Jund,Ctnnb1) 促进TLC命运.
结论:
- 特定的基因调节网络和关键因素在重新编程过程中决定细胞命运.
- 识别这些驱动因素为避免选择性命运和改善重编程结果提供了一种策略.
- 这项研究加深了在诱导多能性背景下对细胞命运决定的理解.
相关概念视频
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Molecular Factors Affecting Cell Division
3.1K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.1K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K


